Virtu Financial LLC Caladrius Biosciences, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$0.63 - $1.03 $100,967 - $165,073	-160,266 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$0.83 - $1.22 $133,020 - $195,524	160,266 New	160,266 $135,000
Q1 2021 May 19, 2021	SELL	$1.44 - $2.89 $75,742 - $152,011	-52,599 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$1.39 - $1.87 $73,112 - $98,360	52,599 New	52,599 $75,000
Q3 2019 Nov 20, 2019	SELL	$2.22 - $2.99 $25,800 - $34,749	-11,622 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.25 - $3.6 $26,149 - $41,839	11,622 New	11,622 $26,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.